person

Valentin R.

Country
France
Department
Service d’hépato-gastro-entérologie et assistance nutritive

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
18
Sites with multiple studies

Has run more than one trial at 18 of 42 partner sites.

Specializations

Gastroenterology and Hepatology

Clinical research activity includes colorectal cancer, gastric cancer, gastroesophageal junction adenocarcinoma, pancreatic adenocarcinoma, cholangiocarcinoma, hepatocellular carcinoma, esophageal cancer, and biliary tract cancer, with additional interest in inflammatory and cholestatic liver disease.

  • Colorectal cancer and rectal cancer
  • Gastric, esophageal, and gastroesophageal junction cancers
  • Hepatocellular carcinoma and biliary tract cancer
  • Crohn’s disease and primary sclerosing cholangitis

The therapeutic focus also extends to digestive neuroendocrine tumors, gastrointestinal stromal tumor, and alcoholic hepatitis, reflecting broad involvement in digestive oncology and liver disease.

Hematology and Blood Cancers

Research interests cover acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndromes, multiple myeloma, lymphoma, Waldenström macroglobulinemia, and myelofibrosis, alongside related precursor and relapsed disease states.

  • Acute lymphoblastic leukemia and acute myeloid leukemia
  • Multiple myeloma and plasma cell disorders
  • Lymphomas including diffuse large B-cell lymphoma and follicular lymphoma
  • Myelodysplastic syndromes and myelofibrosis

Additional activity includes amyloidosis, systemic mastocytosis, mastocytosis, and hemophilia, indicating a strong therapeutic presence across malignant and non-malignant hematologic conditions.

Solid Tumors and Precision Oncology

Clinical trial involvement spans breast cancer, non-small cell lung cancer, renal cell carcinoma, ovarian cancer, prostate cancer, melanoma, head and neck cancer, bladder cancer, and sarcomas, including rare and biomarker-defined malignancies.

  • Breast cancer, including HER2-positive and triple-negative disease
  • Non-small cell lung cancer and ROS1-positive lung cancer
  • Renal cell carcinoma, urothelial carcinoma, and prostate cancer
  • Sarcomas, melanoma, and head and neck squamous cell carcinoma

Interest also includes FGFR-altered tumors, HER2-mutated solid tumors, MSI-H and dMMR cancers, and other biomarker-selected advanced cancers.

Cardiovascular and Thrombotic Disease

Research activity includes acute myocardial infarction, acute coronary syndrome, stroke, atrial fibrillation, heart failure, atherosclerotic cardiovascular disease, hypertension, and pulmonary arterial hypertension, with attention to both prevention and acute management.

  • Acute myocardial infarction and acute coronary syndrome
  • Stroke and transient ischemic attack
  • Atrial fibrillation and cardioembolic risk
  • Heart failure, hypertension, and atherothrombotic disease

Additional therapeutic interest extends to valvular heart disease, cardiac arrest, cardiomyopathy, and venous thromboembolism.

Autoimmune, Inflammatory, and Transplant Conditions

Clinical research includes rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, juvenile idiopathic arthritis, vasculitis, Crohn’s disease, systemic sclerosis, and giant cell arteritis, together with transplant-related immune disorders.

  • Rheumatoid arthritis and juvenile idiopathic arthritis
  • Systemic lupus erythematosus and lupus nephritis
  • Vasculitis and giant cell arteritis
  • Kidney transplantation and graft-versus-host disease

Therapeutic interests also cover immune thrombocytopenia, primary biliary cholangitis, systemic mastocytosis, and pulmonary hypertension linked to inflammatory disease.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.